▶ 調査レポート

嚢胞性線維症(CF)治療薬の世界市場予測 2023年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Cystic Fibrosis (CF) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GlobalInfoResearchが調査・発行した産業分析レポートです。嚢胞性線維症(CF)治療薬の世界市場予測 2023年:メーカー別、地域別、種類・用途別 / Global Cystic Fibrosis (CF) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 / C-GIR011555資料のイメージです。• レポートコード:C-GIR011555
• 出版社/出版日:GlobalInfoResearch / 2018年8月
• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User¥361,920 (USD3,480)▷ お問い合わせ
  Multi User¥542,880 (USD5,220)▷ お問い合わせ
  Corporate User¥723,840 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、嚢胞性線維症(CF)治療薬の世界市場について調査・分析し、嚢胞性線維症(CF)治療薬の世界市場概観、メーカー動向、メーカー別嚢胞性線維症(CF)治療薬シェア、市場規模推移、市場規模予測、嚢胞性線維症(CF)治療薬種類別分析(膵臓酵素サプリメント、粘液溶解剤、気管支拡張薬、CFTR変調器)、嚢胞性線維症(CF)治療薬用途別分析(経口薬、吸入薬)、主要地域分析(北米、欧州、アジア)、主要国分析データなどを含め、以下の構成でお届け致します。
・嚢胞性線維症(CF)治療薬の市場概観
・嚢胞性線維症(CF)治療薬のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・嚢胞性線維症(CF)治療薬のメーカー別販売動向、市場シェア、市場集中度、競争動向
・嚢胞性線維症(CF)治療薬の世界市場規模
・嚢胞性線維症(CF)治療薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・嚢胞性線維症(CF)治療薬のアメリカ市場規模推移
・嚢胞性線維症(CF)治療薬のカナダ市場規模推移
・嚢胞性線維症(CF)治療薬のメキシコ市場規模推移
・嚢胞性線維症(CF)治療薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・嚢胞性線維症(CF)治療薬のドイツ市場規模推移
・嚢胞性線維症(CF)治療薬のイギリス市場規模推移
・嚢胞性線維症(CF)治療薬のロシア市場規模推移
・嚢胞性線維症(CF)治療薬のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・嚢胞性線維症(CF)治療薬の日本市場規模推移
・嚢胞性線維症(CF)治療薬の中国市場規模推移
・嚢胞性線維症(CF)治療薬の韓国市場規模推移
・嚢胞性線維症(CF)治療薬のインド市場規模推移
・嚢胞性線維症(CF)治療薬の東南アジア市場規模推移
・嚢胞性線維症(CF)治療薬の南米・中東・アフリカ市場分析
・嚢胞性線維症(CF)治療薬の種類別分析/市場規模推移(膵臓酵素サプリメント、粘液溶解剤、気管支拡張薬、CFTR変調器)
・嚢胞性線維症(CF)治療薬の用途別分析/市場規模推移(経口薬、吸入薬)
・嚢胞性線維症(CF)治療薬の市場予測(地域別予測、種類別予測、用途別予測)
・嚢胞性線維症(CF)治療薬の販売チャネル・代理店・貿易業者・ディーラー分析

Cystic fibrosis is a genetic disease that causes continuous lung infections and breathing problem over time. It is a progressive disease. The presence of imperfect gene causes a thick, sticky buildup of mucus in the lungs, intestine liver, pancreas, and other organs. The mucus in the lungs clogs airways and traps bacteria leading to infections that causes savior lung damage, and respiratory failure. The mucus prevents in the pancreas discharge the digestive enzymes that allow the body to break down food and absorb vital nutrients. This disease is caused by mutation in gene, cystic fibrosis trans membrane conductance regulator (CFTR) is a membrane protein in vertebrates, a protein required for regulating sweat, mucus and body secretions.

Scope of the Report:

This report focuses on the Cystic Fibrosis (CF) Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Cystic Fibrosis (CF) Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Vertex Pharmaceuticals Incorporated

Gilead

AbbVie, Inc.

Novartis AG

F. Hoffmann-La Roche Ltd

Alaxia

Merck & Co. Inc.

AIT (Advanced Inhalation Therapies)

ALLERGAN

AstraZeneca

Teva Pharmaceutical Industries Ltd

Alcresta

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pancreatic enzyme supplements

Mucolytics

Bronchodilators

CFTR modulators

Market Segment by Applications, can be divided into

Oral drugs

Inhaled drugs

There are 15 Chapters to deeply display the global Cystic Fibrosis (CF) Therapeutics market.

Chapter 1, to describe Cystic Fibrosis (CF) Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cystic Fibrosis (CF) Therapeutics, with sales, revenue, and price of Cystic Fibrosis (CF) Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cystic Fibrosis (CF) Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cystic Fibrosis (CF) Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cystic Fibrosis (CF) Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

レポート目次

Table of Contents

1 Market Overview

1.1 Cystic Fibrosis (CF) Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Pancreatic enzyme supplements

1.2.2 Mucolytics

1.2.3 Bronchodilators

1.2.4 CFTR modulators

1.3 Market Analysis by Applications

1.3.1 Oral drugs

1.3.2 Inhaled drugs

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Vertex Pharmaceuticals Incorporated

2.1.1 Business Overview

2.1.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Gilead

2.2.1 Business Overview

2.2.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 AbbVie, Inc.

2.3.1 Business Overview

2.3.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis AG

2.4.1 Business Overview

2.4.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 F. Hoffmann-La Roche Ltd

2.5.1 Business Overview

2.5.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Alaxia

2.6.1 Business Overview

2.6.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck & Co. Inc.

2.7.1 Business Overview

2.7.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 AIT (Advanced Inhalation Therapies)

2.8.1 Business Overview

2.8.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 ALLERGAN

2.9.1 Business Overview

2.9.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 AstraZeneca

2.10.1 Business Overview

2.10.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Teva Pharmaceutical Industries Ltd

2.11.1 Business Overview

2.11.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Alcresta

2.12.1 Business Overview

2.12.2 Cystic Fibrosis (CF) Therapeutics Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cystic Fibrosis (CF) Therapeutics Manufacturer Market Share in 2017

3.3.2 Top 6 Cystic Fibrosis (CF) Therapeutics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cystic Fibrosis (CF) Therapeutics Market Analysis by Regions

4.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Regions (2013-2018)

4.2 North America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

4.3 Europe Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

4.5 South America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

5 North America Cystic Fibrosis (CF) Therapeutics by Countries

5.1 North America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries

5.1.1 North America Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)

5.2 United States Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

5.3 Canada Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

5.4 Mexico Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

6 Europe Cystic Fibrosis (CF) Therapeutics by Countries

6.1 Europe Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries

6.1.1 Europe Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

6.3 UK Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

6.4 France Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

6.5 Russia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

6.6 Italy Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cystic Fibrosis (CF) Therapeutics by Countries

7.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)

7.2 China Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

7.3 Japan Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

7.4 Korea Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

7.5 India Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

8 South America Cystic Fibrosis (CF) Therapeutics by Countries

8.1 South America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries

8.1.1 South America Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

8.3 Argentina Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

8.4 Colombia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cystic Fibrosis (CF) Therapeutics by Countries

9.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

9.3 UAE Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

9.4 Egypt Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

9.5 Nigeria Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

9.6 South Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

10 Global Cystic Fibrosis (CF) Therapeutics Market Segment by Type

10.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Type (2013-2018)

10.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Pancreatic enzyme supplements Sales Growth and Price

10.2.1 Global Pancreatic enzyme supplements Sales Growth (2013-2018)

10.2.2 Global Pancreatic enzyme supplements Price (2013-2018)

10.3 Mucolytics Sales Growth and Price

10.3.1 Global Mucolytics Sales Growth (2013-2018)

10.3.2 Global Mucolytics Price (2013-2018)

10.4 Bronchodilators Sales Growth and Price

10.4.1 Global Bronchodilators Sales Growth (2013-2018)

10.4.2 Global Bronchodilators Price (2013-2018)

10.5 CFTR modulators Sales Growth and Price

10.5.1 Global CFTR modulators Sales Growth (2013-2018)

10.5.2 Global CFTR modulators Price (2013-2018)

11 Global Cystic Fibrosis (CF) Therapeutics Market Segment by Application

11.1 Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Application (2013-2018)

11.2 Oral drugs Sales Growth (2013-2018)

11.3 Inhaled drugs Sales Growth (2013-2018)

12 Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

12.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2018-2023)

12.2 Cystic Fibrosis (CF) Therapeutics Market Forecast by Regions (2018-2023)

12.2.1 North America Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

12.2.2 Europe Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

12.2.4 South America Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

12.3 Cystic Fibrosis (CF) Therapeutics Market Forecast by Type (2018-2023)

12.3.1 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Type (2018-2023)

12.3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Type (2018-2023)

12.4 Cystic Fibrosis (CF) Therapeutics Market Forecast by Application (2018-2023)

12.4.1 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Application (2018-2023)

12.4.2 Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Cystic Fibrosis (CF) Therapeutics Picture

Table Product Specifications of Cystic Fibrosis (CF) Therapeutics

Figure Global Sales Market Share of Cystic Fibrosis (CF) Therapeutics by Types in 2017

Table Cystic Fibrosis (CF) Therapeutics Types for Major Manufacturers

Figure Pancreatic enzyme supplements Picture

Figure Mucolytics Picture

Figure Bronchodilators Picture

Figure CFTR modulators Picture

Figure Cystic Fibrosis (CF) Therapeutics Sales Market Share by Applications in 2017

Figure Oral drugs Picture

Figure Inhaled drugs Picture

Figure United States Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure France Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure UK Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure China Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure India Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Table Vertex Pharmaceuticals Incorporated Basic Information, Manufacturing Base and Competitors

Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Type and Applications

Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Gilead Basic Information, Manufacturing Base and Competitors

Table Gilead Cystic Fibrosis (CF) Therapeutics Type and Applications

Table Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AbbVie, Inc. Basic Information, Manufacturing Base and Competitors

Table AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Type and Applications

Table AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis AG Basic Information, Manufacturing Base and Competitors

Table Novartis AG Cystic Fibrosis (CF) Therapeutics Type and Applications

Table Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors

Table F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Type and Applications

Table F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Alaxia Basic Information, Manufacturing Base and Competitors

Table Alaxia Cystic Fibrosis (CF) Therapeutics Type and Applications

Table Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors

Table Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Type and Applications

Table Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AIT (Advanced Inhalation Therapies) Basic Information, Manufacturing Base and Competitors

Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Type and Applications

Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table ALLERGAN Basic Information, Manufacturing Base and Competitors

Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Type and Applications

Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Type and Applications

Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Type and Applications

Table Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Alcresta Basic Information, Manufacturing Base and Competitors

Table Alcresta Cystic Fibrosis (CF) Therapeutics Type and Applications

Table Alcresta Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Cystic Fibrosis (CF) Therapeutics Sales by Manufacturer (2016-2017)

Figure Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Manufacturer in 2016

Figure Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Manufacturer in 2017

Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Manufacturer (2016-2017)

Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Manufacturer in 2016

Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Manufacturer in 2017

Figure Top 3 Cystic Fibrosis (CF) Therapeutics Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Cystic Fibrosis (CF) Therapeutics Manufacturer (Revenue) Market Share in 2017

Figure Global Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Global Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)

Table Global Cystic Fibrosis (CF) Therapeutics Sales by Regions (2013-2018)

Table Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Regions (2013-2018)

Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Regions (2013-2018)

Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Regions in 2013

Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Regions in 2017

Figure North America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Europe Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure South America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure North America Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)

Table North America Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)

Table North America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)

Figure North America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2013

Figure North America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2017

Table North America Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)

Table North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2013

Figure North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017

Figure United States Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Canada Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Mexico Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Europe Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)

Table Europe Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)

Table Europe Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)

Table Europe Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)

Figure Europe Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2016

Figure Europe Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017

Figure Germany Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure UK Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure France Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Russia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Italy Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)

Table Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries 2017

Table Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)

Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries 2017

Figure China Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Japan Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Korea Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure India Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure South America Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)

Table South America Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)

Table South America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)

Figure South America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2017

Table South America Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)

Table South America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017

Figure Brazil Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Argentina Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Colombia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)

Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2017

Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)

Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2013

Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017

Figure Saudi Arabia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure UAE Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Egypt Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure Nigeria Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Figure South Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)

Table Global Cystic Fibrosis (CF) Therapeutics Sales by Type (2013-2018)

Table Global Cystic Fibrosis (CF) Therapeutics Sales Share by Type (2013-2018)

Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Type (2013-2018)

Table Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Type (2013-2018)

Figure Global Pancreatic enzyme supplements Sales Growth (2013-2018)

Figure Global Pancreatic enzyme supplements Price (2013-2018)

Figure Global Mucolytics Sales Growth (2013-2018)

Figure Global Mucolytics Price (2013-2018)

Figure Global Bronchodilators Sales Growth (2013-2018)

Figure Global Bronchodilators Price (2013-2018)

Figure Global CFTR modulators Sales Growth (2013-2018)

Figure Global CFTR modulators Price (2013-2018)

Table Global Cystic Fibrosis (CF) Therapeutics Sales by Application (2013-2018)

Table Global Cystic Fibrosis (CF) Therapeutics Sales Share by Application (2013-2018)

Figure Global Inhaled drugs Sales Growth (2013-2018)

Figure Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2018-2023)

Table Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Regions (2018-2023)

Table Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Regions (2018-2023)

Figure North America Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

Figure Europe Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

Figure Asia-Pacific Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

Figure South America Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

Figure Middle East and Africa Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)

Table Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Type (2018-2023)

Table Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Type (2018-2023)

Table Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Application (2018-2023)

Table Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List